Histamine H3 receptors regulate vascular permeability changes in the skin of mast cell-deficient mice

International Immunopharmacology

Volumn 3, Issue 12, 2003, Pages 1563-1568

  Hossen, Maria Alejandra ^a   Fujii, Yoko ^a   Sugimoto, Yukio ^a   Kayasuga, Ryoji ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

H3 agonists; H3 antagonists; Histamine; Vascular permeability

Indexed keywords

3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; CHLORPHENIRAMINE; CLOBENPROPIT; DIPHENHYDRAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; IODOPHENPROPIT; N ACETYLTRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; 3,5 BIS(TRIFLUOROMETHYL)BENZYL N ACETYLTRYPTOPHAN; 3,5-BIS(TRIFLUOROMETHYL)BENZYL N-ACETYLTRYPTOPHAN; 4 (1H IMIDAZOL 4 YLMETHYL)PIPERIDINE; 4-(1H-IMIDAZOL-4-YLMETHYL)PIPERIDINE; ANTIHISTAMINIC AGENT; DRUG DERIVATIVE; EVANS BLUE; HISTAMINE; HISTAMINE AGONIST; IMIDAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE; THIOUREA; THIOUREA DERIVATIVE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; KNOCKOUT MOUSE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN PERMEABILITY; SPECIES COMPARISON; WILD TYPE; ANIMAL; CAPILLARY PERMEABILITY; DRUG EFFECT; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKIN; VASCULARIZATION;

ANIMALS; CAPILLARY PERMEABILITY; CHLORPHENIRAMINE; DIPHENHYDRAMINE; EVANS BLUE; FEMALE; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; IMIDAZOLES; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENOUS; ISOTHIURONIUM; MAST CELLS; MICE; MICE, MUTANT STRAINS; PIPERIDINES; RECEPTORS, HISTAMINE H3; SKIN; THIOUREA; TRYPTOPHAN;

EID: 0141637398     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00009-2     Document Type: Article

References (27)

1. Killackey J.J.F., Johnston M.G., Movat H.Z. Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. Am. J. Pathol. 122:1986;50-61.
2. Grega G.J. Contractile elements in endothelial cells as potential targets for drug action. Trends Pharmacol. Sci. 7:1986;452-457.
3. 1-antihistaminic compound levocabastine. Arzneim.-Forsch./Drug Res. 43(II):1993;1331-1337.
4. Kamei C., Mio M., Izushi K., Kitazumi K., Tsujimoto S.et al. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs. Arzneim.-Forsch./Drug Res. 41(II):1991;932-936.
5. 1 receptor-deficient mice. Int. Immunopharmacol. 2:2002;745-750.
6. 3) of histamine receptor. Nature. 302:1983;832-837.
7. 3 -receptors. Nature. 327:1987;117-123.
8. 3) of histamine receptors on perivascular nerve terminals. Nature. 327:1987;158-161.
9. Falus A., Merétey K. Histamine: an early messenger in inflammatory and immune reactions. Trends Pharmacol. Sci. 13:1992;154-156.
10. v mice and their increase by bone marrow transplantation. Blood. 52:1978;447-452.
11. v alleles on production of tissue mast cells in mice. J. Hered. 71:1980;41-44.
12. Watanabe T., Maeyama K., Yamatodani A., Yamada M., Kitamura Y.et al. Histidine decarboxylase activities in mutant mice deficient in mast cells. Life Sci. 26:1980;1569-1574.
13. Ohtsuka E., Kawai S., Ichikawa T., Nojima H., Kitagawa K.et al. Roles of mast cells and histamine in mosquito bite-induced allergic itch-associated responses in mice. Jpn. J. Pharmacol. 86:2001;97-105.
14. Sugimoto Y., Tarumi T., Zhao Q.E., Fujii Y., Kamei C. Effects of antiallergic drugs on histamine release from rat peritoneal mast cells induced by bradykinin. Methods Find. Exp. Clin. Pharmacol. 20:1998;457-462.
15. 3-receptors on the spontaneous and ConA induced histamine release from human adenoidal mast cells. Agents Actions. 33:1991;67-70.
16. 3 receptor agonist Rα methylhistamine in human skin. Br. J. Dermatol. 138:1998;622-626.
17. 3 receptors in isolated perfused rabbit lungs. Eur. J. Pharmacol. 277:1995;243-250.
18. Foreman J.C. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int. Arch. Allergy Appl. Immunol. 82:1987;366-371.
19. Devillier P., Regoli D., Asseraf A., Descours B., Marsac J.et al. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology. 32:1986;340-347.
20. 3-receptor modulation in rat lung and spleen. Clin. Sci. 87:1994;151-163.
21. 3 receptors. Eur. J. Pharmacol. 273:1995;83-88.
22. Malaviya R., Morrison A.R., Pentland A.P. Histamine in human epidermal cells is induced by ultraviolet light injury. J. Invest. Dermatol. 106:1996;785-789.
23. Hägermark Ö., Hökfelt T., Pernow B. Flare and itch induced by substance P in human skin. J. Invest. Dermatol. 71:1978;233-235.
24. Foreman J.C., Jordan C.C., Oehme P., Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J. Physiol. 335:1983;449-465.
25. Yamaji M., Takada M., Fujiwara R., Ohishi H., Izushi K.et al. Role of substance P in experimental allergic conjunctivitis in guinea pigs. Methods Find. Exp. Clin. Pharmacol. 19:1997;637-643.
26. Yano H., Wershil B.K., Arizono N., Galli S.J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J. Clin. Invest. 84:1989;1276-1286.
27. Ramos B.F., Zhang Y., Angkachatchai V., Jakschik B.A. Mast cell mediators regulate vascular permeability changes in Arthus reaction. J. Pharmacol. Exp. Ther. 262:1992;559-565.